Literature DB >> 31150774

Development of PLGA microparticles with high immunoglobulin G-loaded levels and sustained-release properties obtained by spray-drying a water-in-oil emulsion.

Audrey Arrighi1, Sarah Marquette2, Claude Peerboom2, Laurence Denis2, Jonathan Goole3, Karim Amighi3.   

Abstract

In this study, the possibility of producing highly antibody-loaded microparticles with sustained-release properties was evaluated. Polyclonal immunoglobulin G (IgG) was used as a model of antibody and its encapsulation into poly(lactide-co-glycolide) acid (PLGA) microparticles was performed by spray-drying a water-in-oil (w/o) emulsion. It was demonstrated that the use of the Resomer® RG505 PLGA allowed an IgG loading of 20% w/w with an encapsulation efficiency higher than 85%. The produced microparticles were characterized by a mean diameter lower than 10 µm. The burst effect was shown to reach a maximal value of 40%. IgG stability after encapsulation was also assessed. The use of this single PLGA provided a lag time of 3 months which dramatically slowed down the release rate after the initial release of the encapsulated IgG. Using blends of PLGA characterized by different inherent viscosities allowed decreasing the lag time and modulating the dissolution profile of the IgG from the spray-dried microparticles. Therefore, spray-drying a water-in-oil emulsion appeared to be a promising strategy to produce highly antibody-loaded microparticles characterized by sustained-release properties.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Microparticles; Poly(lactide-co-glycolide) acid (PLGA); Spray-drying; Sustained-release; Water-in-oil emulsion

Mesh:

Substances:

Year:  2019        PMID: 31150774     DOI: 10.1016/j.ijpharm.2019.05.070

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo.

Authors:  Yue Su; Jia Liu; Songwen Tan; Wenfang Liu; Rongrong Wang; Chuanpin Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  An overview on the investigation of nanomaterials' effect on plasma components: immunoglobulins and coagulation factor VIII, 2010-2020 review.

Authors:  Tahereh Zadeh Mehrizi; Kamran Mousavi Hosseini
Journal:  Nanoscale Adv       Date:  2021-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.